Why competition in the market for obesity drugs just got tougher
The emerging battle for market share in the lucrative obesity market, which analysts at Goldman Sachs estimate could be worth more than $100 billion by 2030, is starting to heat up.Sales of market-leading weight-loss drug Wegovy...
09 May 2024
